Armodafinil and Basaglar drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Armodafinil (armodafinil) and Basaglar (insulin glargine). Common drug interactions include arthralgia among females and anxiety among males.

The phase IV clinical study analyzes what interactions people have when they take Armodafinil and Basaglar. It is created by eHealthMe based on reports of 12 people who take the same drugs from the FDA, and is updated regularly.

What is Armodafinil?

Armodafinil has active ingredients of armodafinil. It is often used in narcolepsy. eHealthMe is studying from 4,136 Armodafinil users. Check the latest studies of Armodafinil.

What is Basaglar?

Basaglar has active ingredients of insulin glargine. eHealthMe is studying from 19,807 Basaglar users. Check the latest studies of Basaglar.

On Jul, 18, 2026

12 people who take Armodafinil and Basaglar together, and have interactions are studied.

Armodafinil and Basaglar drug interactions.

What are the common drug interactions of Armodafinil and Basaglar, by gender? *:

female:

Arthralgia (joint pain)
Fall
Gait disturbance
Mobility decreased (ability to move is reduced)
Muscle spasms (muscle contraction)
Muscular weakness (muscle weakness)
Myalgia (muscle pain)
Secondary progressive multiple sclerosis (a stage of ms which comes after relapsing remitting ms in many cases)
Tremor (trembling or shaking movements in one or more parts of your body)
Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)

male:

Anxiety
Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Blood cholesterol increased
Blood ketone body present
Cellulitis (infection under the skin)
Cerebral haemorrhage (bleeding within the brain)
Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
Confusional state
Constipation
Diarrhoea

What are the common drug interactions of Armodafinil and Basaglar, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Cerebral haemorrhage (bleeding within the brain)
Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
Confusional state
Dizziness
Dyspnoea (difficult or laboured respiration)
Hypoaesthesia (reduced sense of touch or sensation)
Nausea (feeling of having an urge to vomit)

40-49:

n/a

50-59:

Arthralgia (joint pain)
Fall
Fatigue (feeling of tiredness)
Headache (pain in head)
Hepatic enzyme increased
Infusion related reaction
Multiple allergies (allergy to multiple agents)
Nasopharyngitis (inflammation of the nasopharynx)
Pain
Pyrexia (fever)

60+:

n/a

What are the existing conditions these people have? *

Cataplexy (loss of muscle tone accompanied by full conscious awareness): 9 people, 75.00%
Pulmonary Hypertension (increase in blood pressure in the lung artery): 1 person, 8.33%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 1 person, 8.33%
Immunodeficiency Common Variable: 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Armodafinil and Basaglar?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously